Isao Oze

5.9k total citations
139 papers, 2.5k citations indexed

About

Isao Oze is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Isao Oze has authored 139 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 46 papers in Pulmonary and Respiratory Medicine and 40 papers in Surgery. Recurrent topics in Isao Oze's work include Esophageal Cancer Research and Treatment (22 papers), Lung Cancer Treatments and Mutations (18 papers) and Gastric Cancer Management and Outcomes (17 papers). Isao Oze is often cited by papers focused on Esophageal Cancer Research and Treatment (22 papers), Lung Cancer Treatments and Mutations (18 papers) and Gastric Cancer Management and Outcomes (17 papers). Isao Oze collaborates with scholars based in Japan, United States and Italy. Isao Oze's co-authors include Keitaro Matsuo, Hidemi Ito, Satoyo Hosono, Hideo Tanaka, Miki Watanabe, Yasuhisa Hasegawa, Yasushi Yatabe, Katsuyuki Hotta, Katsuyuki Kiura and Daisuke Kawakita and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Isao Oze

134 papers receiving 2.4k citations

Peers

Isao Oze
Isao Oze
Citations per year, relative to Isao Oze Isao Oze (= 1×) peers Francesco Ferraù

Countries citing papers authored by Isao Oze

Since Specialization
Citations

This map shows the geographic impact of Isao Oze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Oze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Oze more than expected).

Fields of papers citing papers by Isao Oze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Oze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Oze. The network helps show where Isao Oze may publish in the future.

Co-authorship network of co-authors of Isao Oze

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Oze. A scholar is included among the top collaborators of Isao Oze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Oze. Isao Oze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ninomiya, Kiichiro, Shinobu Hosokawa, Toshihide Yokoyama, et al.. (2025). Phase II Study of Platinum Re-administration in Non-small Cell Lung Cancer Following Chemoimmunotherapy Resistance. Cureus. 17(5). e84709–e84709. 1 indexed citations
3.
4.
Morita, Ayako, Eiki Ichihara, Koji Inoue, et al.. (2024). Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer. International Journal of Cancer. 154(9). 1607–1615. 14 indexed citations
5.
Ichihara, Eiki, Toshihide Yokoyama, Tomoki Tamura, et al.. (2024). Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. Cancers. 16(23). 4089–4089. 2 indexed citations
7.
Iwase, Madoka, Yukari Taniyama, Yuriko N. Koyanagi, et al.. (2024). A Century of Change: Unraveling the Impact of Socioeconomic/Historical Milestones on Age at Menarche and Other Female Reproductive Factors in Japan. Journal of Epidemiology. 34(8). 387–392. 6 indexed citations
8.
Abe, Tetsuya, Koji Komori, Seiji Ito, et al.. (2023). Maximum phonation time: an independent predictor of late-onset pneumonia after esophageal cancer surgery. Diseases of the Esophagus. 36(10). 3 indexed citations
9.
Matsubara, Yuki, Kazuhiro Toriyama, Shigenori Kadowaki, et al.. (2023). The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma. Esophagus. 20(3). 524–532. 4 indexed citations
10.
Hosokawa, Shinobu, Eiki Ichihara, Daijiro Harada, et al.. (2022). Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801. International Journal of Clinical Oncology. 27(7). 1139–1144. 4 indexed citations
11.
Hasegawa, Yasuhisa, Kiyoaki Tsukahara, Seiichi Yoshimoto, et al.. (2021). Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial. Journal of Clinical Oncology. 39(18). 2025–2036. 71 indexed citations
12.
Koyanagi, Yuriko N., Isao Oze, Yumiko Kasugai, et al.. (2020). Association between Socioeconomic Status and Digestive Tract Cancers: A Case-Control Study. Cancers. 12(11). 3258–3258. 10 indexed citations
13.
Fujimoto, Nobukazu, Keisuke Aoe, Toshiyuki Kozuki, et al.. (2018). A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol. Clinical Lung Cancer. 19(5). e705–e707. 20 indexed citations
14.
Taniguchi, Akihiko, Nobuaki Miyahara, Naohiro Oda, et al.. (2017). Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease.. PubMed. 71(5). 453–457. 4 indexed citations
15.
Hosono, Satoyo, Hidemi Ito, Isao Oze, et al.. (2017). Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993–2000 to 2001–2006 in Japan. Journal of Epidemiology. 28(2). 75–80. 5 indexed citations
16.
Nakane, Hideo, Minoru Hirano, Hidemi Ito, et al.. (2014). Impact of metallothionein gene polymorphisms on the risk of lung cancer in a Japanese population. Molecular Carcinogenesis. 54(S1). E122–8. 10 indexed citations
17.
Ebi, Hiromichi, Isao Oze, Takayuki Nakagawa, et al.. (2014). Lack of Association between the BIM Deletion Polymorphism and the Risk of Lung Cancer with and without EGFR Mutations. Journal of Thoracic Oncology. 10(1). 59–66. 11 indexed citations
18.
Park, Jun Yong, Keitaro Matsuo, Takeshi Suzuki, et al.. (2010). Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population. Carcinogenesis. 31(4). 660–665. 36 indexed citations
19.
Oze, Isao, Keitaro Matsuo, Takeshi Suzuki, et al.. (2009). Impact of Multiple Alcohol Dehydrogenase Gene Polymorphisms on Risk of Upper Aerodigestive Tract Cancers in a Japanese Population. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3097–3102. 54 indexed citations
20.
Segawa, Yoshihiko, Masanori Fujii, Isao Oze, et al.. (2009). Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications. Journal of Cancer Research and Clinical Oncology. 135(8). 1055–1059. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026